Kymera Therapeutics

A biotechnology company pioneering a transformative new approach to treating previously untreatable diseases.

Launch date

2016

Employees

Market cap

Net debt

-

Enterprise valuation

$1.9b (Public information from May 2024)

Cambridge Massachusetts (HQ)

http://kymeratx.com

https://twitter.com/kymeratx https://www.linkedin.com/company/kymeratherapeutics/

No columns specified